Medrx Co.,Ltd.
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
4586 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 東かがわ市西山４３１番地７
- Website:
- https://www.medrx.co.jp/english/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Medrx Co., Ltd., established in 2002, is a pharmaceutical company focused on drug formulation development. The company specializes in creating new dosage forms and value-added medicines, with a core technological expertise in transdermal absorption and drug delivery systems. Medrx conducts research and development to create innovative pharmaceutical candidates, which it then licenses to other companies for final clinical trials, production, and commercialization. The company's primary goal is to improve global health and patient quality of life by developing medications that offer alternatives to conventional oral administration, thereby improving patient adherence and therapeutic effectiveness.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Medrx Co.,Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-08 08:33 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-08-08 08:31 |
Interim Report
半期報告書－第24期(2025/01/01－2025/12/31)
|
Japanese | 425.8 KB | |
| 2025-06-13 08:31 |
Regulatory News Service
臨時報告書
|
Japanese | 39.1 KB | |
| 2025-03-31 08:33 |
Regulatory News Service
内部統制報告書－第23期(2024/01/01－2024/12/31)
|
Japanese | 23.9 KB | |
| 2025-03-31 08:32 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-03-31 08:32 |
Regulatory News Service
臨時報告書
|
Japanese | 25.0 KB | |
| 2025-03-31 08:32 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 271.6 KB | |
| 2025-03-31 08:31 |
Annual Report
有価証券報告書－第23期(2024/01/01－2024/12/31)
|
Japanese | 1.4 MB | |
| 2025-03-28 07:31 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 268.0 KB | |
| 2025-03-25 07:31 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 409.6 KB | |
| 2024-08-09 08:01 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-08-09 08:00 |
Interim Report
半期報告書－第23期(2024/01/01－2024/12/31)
|
Japanese | 345.0 KB | |
| 2024-05-17 08:01 |
Regulatory News Service
臨時報告書
|
Japanese | 39.2 KB | |
| 2024-05-10 08:02 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-05-10 08:01 |
Quarterly Report
四半期報告書－第23期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 408.3 KB |
Automate Your Workflow. Get a real-time feed of all Medrx Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Medrx Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
